A nationwide shortage of BCG vaccines is leaving Kenyan newborns vulnerable to TB, a disease with high prevalence, health ...

Health Non-Governmental Organisations Network (HENNET) has blamed low budgetary allocation for the recurring vaccine ...

With only seven members, iGEM Eindhoven forms a small but determined student team that aims to help shape the future of ...

JNJ's regulatory filing seeks the FDA's approval for TAR-200, a drug-device combination for treating certain bladder cancer ...

Indeed, the BCG vaccine was invented whether the leprosy world asked for it or not; and it has not been necessary to consider the need for neonatal BCG vaccination to prevent leprosy, or to ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

There is consistent evidence that BCG protects against leprosy ... analysis to be carried out to assess the difference of vaccine protection conferred for children vaccinated before 15 years ...

This challenge is largely attributed to the government’s failure to properly project population growth. Approximately one ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced significant progress in its ongoing discussions with the U.S. Food and Drug Administration (FDA) regarding three areas of its ...